Konica Minolta
VC Fund
Tokyo, Japan
Konica Minolta is a VC fund in Tokyo focused on Artificial Intelligence and Robotics. Konica Minolta Inc. is an Innovative Company and continues to create inspiring products and services in the field of imaging. An innovative corporation that continues to create inspiring products and services in the field of imaging. A global corporation that leads the market by advanced technologies and reliability. The Konica Minolta brandshows intellectual creativity with its challenging, reliable, friendly personality. Four unique characteristics help realize the ideal value of the brand: broad technical expertise covering the entire imaging field; a culture relentlessly committed to creating great products and services; unique product groups developed from integrated technologies; a marketing service network that swiftly copes with customers’ needs.The essence of their brand is Konica Minolta’s comprehensive technological expertise that yields highly original innovations, which are a constant source of surprise to customers. The logo is a representation of their brand value and company name and expresses what Konica Minolta offers to customers. The Konica Minolta Group owns a wide array of specialized technologies and technologies that support the competitiveness and attractiveness of their products. These technologies are defined as our core technologies, totaling twelve – four in materials, two in optics, two in nano-fabrication and four in imaging fields. Throughout their history, they have expanded and advanced these technologies, integrating them at whole new levels so that they are the driving force of our production activities. They continuously strive to integrate these technologies into innovative products with new functions and added value that contribute to the daily lives of people at home and at work. Naturally, this also includes our range of Business Solution products.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Konica Minolta invests in
Stages Konica Minolta invests in
Countries Konica Minolta invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Artificial Intelligence 3 (60%)
- Robotics 2 (40%)
- Medical 1 (20%)
- Hardware 1 (20%)
- Security 1 (20%)
Stage
- Series A 2 (40%)
- Seed 1 (20%)
- Series B 1 (20%)
- Equity Crowdfunding 1 (20%)
Country
- Japan 3 (60%)
- United States 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Indy Nakagawa
Senior Executive Officer
|
Senior Executive Officer | Total investments: 0 | Find email | |
Jordan Liebman
SVP of Marketing and Communications
|
SVP of Marketing and Communications | Total investments: 0 | Find email | |
Milan Lakhani
Innovation Strategist & Incubation Manager
|
Innovation Strategist & Incubation Manager | Total investments: 0 | Find email | |
Brock Brown
Senior Account Executive
|
Senior Account Executive | Total investments: 0 | Find email | |
Masatoshi Matsuzaki
Founder &CEO
|
Founder &CEO | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CROSS SYNC
|
The company was founded in October 2019 by Dr. Takaki, a Japanese intensivist with more than 20-year experience in critical care medicine, from his strong desire of wanting to decrease preventable death and sudden changes in patient conditions while in the ICU. CROSS SYNC’s vision is to provide ICU-level medical treatment anywhere. The mission isto help and assist medical professionals utilizing the power of technology so that they can provide high-quality medical care even in an environment where there is a shortage of specialist physicians, and to ensure the best patient outcomes. As a Yokohama University certified startup, CROSS SYNC develops a variety of AI clinical assistant tools in collaboration with affiliated hospitals, the school of medicine, and the department of health data science. By delivering our AI-based platform to acute care settings all over the world, we aim to create a world without avoidable deaths and preventable acute changes for in-patients. | $1.4M / Seed / Mar 08, 2021 | |
Welmo
|
WELMO has currently been working on R&D to launch Japan's largest welfare AI service platform called "CPA(Care Plan Assistant)" which supports care coordinator (caregiver), who helps a daily activities of the elderly people, to create a care plan for them, with using ICT and advanced technology, especially NLP(Natural LanguageProcessing), in terms of knowledge support. It has mainly two fundamental technologies; data warehouse includes all fast date and big date about care, explainable AI that describes a reason why the care is provided for the users. It also reduces time and cost to create the care plan, which enables anyone to be able to use easily and get enough information that the users want to know and use. | $170.1M / Series B / Aug 22, 2019 | |
Ispace Technologies
|
Ispace Technologies is a space resource exploration company founded in 2013 to develop micro-robots that will locate the resources necessary to extend human life into outer space. Their main focus is to locate, extract, and deliver lunar ice to customers in cis-lunar space.Ispace manages the technological and business development operations ofTeam HAKUTO in the Google Lunar XPRIZE Competition. Team Hakuto is a front runner in the $30M competition to land a privately funded robot on the Moon and was one of only three teams to win a $500,000 Milestone Prize in mobility.Ispace utilizes 3D printed and commercially off the shelf products (COTS) for rapid prototyping while maximizing structural mass efficiency and shortening the developmental life cycle. Their micro-robots are able to explore larger areas of the Moon faster, at a fraction of the cost of large robots. | $90.2M / Series A / Dec 13, 2017 | |
Knightscope
|
Knightscope develops autonomous security robots that predict and prevent crimes. Its technology is a combination of self-driving technology, robotics, and artificial intelligence. It markets the K1 stationary machine, the K3 indoor machine, and the K5 outdoor machine. A K7 multi-terrain four-wheel version is under development. | $26M / Equity Crowdfunding / Sep 21, 2017 | |
|
Knightscope
|
Knightscope develops autonomous security robots that predict and prevent crimes. Its technology is a combination of self-driving technology, robotics, and artificial intelligence. It markets the K1 stationary machine, the K3 indoor machine, and the K5 outdoor machine. A K7 multi-terrain four-wheel version is under development. | $3.8M / Series A / Dec 02, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Konica Minolta invest in?
Konica Minolta invests primarily in Artificial Intelligence, Robotics and Medical startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Konica Minolta?
Public channels for Konica Minolta include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Konica Minolta?
The team at Konica Minolta includes Indy Nakagawa (Senior Executive Officer), Jordan Liebman (SVP of Marketing and Communications) and Milan Lakhani (Innovation Strategist & Incubation Manager), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
